Dr. Zoe McElligott and colleagues discover surprising details about xylazine in combination with fentanyl
May 31, 2024
Bowles Center for Alcohol Studies faculty Zoe McElligott, PhD, and colleagues found that the animal tranquilizer xylazine activates opioid receptors in the brain, suggesting a reason why the treatment naloxone triggers a more severe withdrawal response when given to individuals on fentanyl/xylazine and suffering from respiratory depression. Read the ºÚÁÏÍø...